Liz Evans and Dan Small from the PHS Community Services Society will be in the UK to hold free public presentations on the Story of North America's only supervised injection site, InSite.
Thursday July 12th 2012, 1 pm
St Martin in-the-Fields, St Martin's Hall, Trafalgar Square, London
Thursday July 19th 2012, 1 pm
Trinity Arts Centre, Main Hall, Trinity Road, Bristol
The PHS Community Services Society, based in Vancouver, Canada, provides basic services from housing and emergency shelters, nutrition, banking, a medical and dental clinic, detox and harm reduction services including a managed alcohol program, needle exchange, alcohol and drug treatment programs and operates North America's first and only safe injection site, InSite.
Liz Evans from Vancouver, Canada, a Psychiatric Nurse, is the Executive Director and founder of the PHS Community Services. For her work in Vancouver's Downtown Eastside, Liz is a recipient of the RNABC as the Health Advocate of the year, she was named one of Canada's Top 40 under 40, received the Denise Leblanc Memorial Award by the BC Non Profit Housing Association, and the Queen's Golden Jubilee Award for Community Services. Liz will talk about the founding and the struggles to keep our safe injection site, a service that save lives, tax dollars and encourages people to use detox, to remain open.
Dr. Dan Small is a Director and co-founder of the PHS Community Services Society and an advocate for a comprehensive evidence approach to dealing with the issue of addiction reduction, social policy and justice. He played a lead role in the establishment of InSite and its victory to remain open. Dr. Dan Small, PhD, M.Phil, is a University of British Columbia Medical Anthropology Professor and Finance Chair of the Medical Council of Canada.
This video link is of their Victory Day when the PHS won their Supreme court battle for the only place in North America where you can safely inject illegal drugs.
InSite for Community provides background on InSite and includes over 40 reports and peer reviewed articles including those published in the British Medical Journal and The Lancet.
Please direct all inquiries to email@example.com
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.